Ipsen SA
XMUN:I7G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ipsen SA
XMUN:I7G
|
FR |
|
O
|
Ono Pharmaceutical Co Ltd
XMUN:ON4
|
JP |
|
K
|
Krakatau Steel (Persero) Tbk PT
XMUN:07K
|
ID |
|
Banca Monte dei Paschi di Siena SpA
MIL:BMPS
|
IT |
Wall St Price Targets
I7G Price Targets Summary
Ipsen SA
According to Wall Street analysts, the average 1-year price target for I7G is 166.81 EUR with a low forecast of 117.39 EUR and a high forecast of 241.98 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I7G's stock price target?
Price Target
166.81
EUR
According to Wall Street analysts, the average 1-year price target for I7G is 166.81 EUR with a low forecast of 117.39 EUR and a high forecast of 241.98 EUR.
What is the Revenue forecast for Ipsen SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Ipsen SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Ipsen SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Ipsen SA?
Projected CAGR
33%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 33%.
What is the Net Income forecast for Ipsen SA?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Net Income has been 64%. The projected CAGR for the next 3 years is 37%.
